Binnogene

Binnogene

毕诺济生物

Binnogene

Biotech/Healthcare

Binuo Jisheng Biotechnology focuses on the R&D and translation of cutting-edge cell therapy technologies, with the goal of becoming a global leader in innovative cell therapies for cancer and autoimmune diseases. The company specializes in novel T-cell therapies and has built proprietary platforms…

Latest round: Angel Extension (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-08-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.